在RAS/RAF复合体内的II型RAF抑制剂的原体选择性
James D Vasta1, Ani Michaud1, Chad A Zimprich1
1Promega Corporation, Madison, WI, USA.
Cell chemical biology
|August 29, 2023
概括
RAF二分体抑制剂通过结合RAF原体来向RAF和RAS驱动的癌症. 一种新方法表明,ARAF的参与,而不是BRAF或CRAF,与细胞中MAPK通路的抑制相关.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由RAF和RAS驱动的癌症代表了重大的治疗挑战.
- 通过准RAS-RAF信号综合体,RAF二聚体抑制剂具有前景.
- 有效的药物效用取决于同时与RAF原体两种结合.
研究的目的:
- 开发和验证一种方法来量化在细胞环境中的活性RAS-RAF复合体内的特定RAF原体的药物向占用率.
- 为了评估英国皇家空军的目标接触,无论KRAS突变状态如何.
- 评估细胞环境对RAF二聚体抑制剂高亲和状态的影响.
主要方法:
- 开发一种条件定量方法,用于RAF原体中的药物位占用.
- 测量RAF在突变KRAS等位基因存在或不存在时的目标接触.
- 对临床阶段II型RAF抑制剂的细胞内原体选择性的评估.
主要成果:
- 一种新的方法允许量化RAS-RAF复合体内的RAF原体的药物向参与.
- 临床阶段的II型RAF抑制剂显示出对ARAF前列体参与的选择性,而不是BRAF或CRAF.
- 与BRAF或CRAF不同的是,ARAF的原型分子参与与各种突变RAS细胞系的MAPK信号抑制相关.
结论:
- 在突变RAS驱动的信号通路中,ARAF起着至关重要的作用.
- 该研究揭示了目前正在临床试验中的几个RAF抑制剂的有限ARAF原体脆弱性.
- 向RAF可能是针对特定癌症有效使用RAF抑制剂治疗的关键策略.
相关概念视频
02:38The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K
01:07MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
01:24Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
01:14Rab Proteins
4.0K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.0K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
01:25Dose-Response Relationship: Selectivity and Specificity
6.9K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.9K